Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized open-label study of deferasirox granules versus tablets in pediatric iron overload
2013-004739-55Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of deferasirox in iron overload and anaemia (2 arms), sponsored by Novartis. Primary endpoint: Compliance measured by stick pack/tablet count over 24 weeks of treatment. Started Aug 2015; status: completed.
02
Drugs
deferasirox
03
Conditions
iron overloadanaemia
Beyond the preview
Go deeper on 2013-004739-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004739-55.